Back to FATE
MARSHALL WACE, LLP FATE Position History
Fate Therapeutics, Inc. • Healthcare
Quarters held
23
Latest value
$1.3M
Q2 2026
Peak value
$18.5M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $151K |
| Q1 2024 | $2.5M |
| Q2 2024 | $1.1M |
| Q2 2024 | $328 |
| Q2 2024 | $1.1M |
| Q4 2024 | $321 |
| Q4 2024 | $7.5M |
| Q4 2024 | $118K |
| Q4 2024 | $6K |
| Q4 2024 | $840K |
| Q1 2025 | $1.9M |
| Q1 2025 | $8M |
| Q1 2025 | $15K |
| Q2 2025 | $5.4M |
| Q2 2025 | $18.5M |
| Q2 2025 | $4K |
| Q3 2025 | $649K |
| Q3 2025 | $9.7M |
| Q3 2025 | $79K |
| Q4 2025 | $1.2M |
| Q4 2025 | $950K |
| Q4 2025 | $394K |
| Q2 2026 | $1.3M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $1.3M | 492.4K | — | — |
| Q4 2025 | $394K | 38.8K | — | — |
| Q4 2025 | $950K | 93.3K | — | — |
| Q4 2025 | $1.2M | 122.7K | — | — |
| Q3 2025 | $79K | 9.3K | — | — |
| Q3 2025 | $9.7M | 1.14M | — | — |
| Q3 2025 | $649K | 75.9K | — | — |
| Q2 2025 | $4K | 559 | — | — |
| Q2 2025 | $18.5M | 2.62M | — | — |
| Q2 2025 | $5.4M | 762.0K | — | — |
| Q1 2025 | $15K | 19.2K | — | — |
| Q1 2025 | $8M | 1.27M | — | — |
| Q1 2025 | $1.9M | 305.2K | — | — |
| Q4 2024 | $840K | 509.2K | — | — |
| Q4 2024 | $6K | 3.5K | — | — |
| Q4 2024 | $118K | 12.5K | — | — |
| Q4 2024 | $7.5M | 794.5K | — | — |
| Q4 2024 | $321 | 34 | — | — |
| Q2 2024 | $1.1M | 330.0K | — | — |
| Q2 2024 | $328 | 100 | — | — |
| Q2 2024 | $1.1M | 151.2K | — | — |
| Q1 2024 | $2.5M | 345.4K | — | — |
| Q1 2024 | $151K | 11.7K | — | — |